| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 06/13/2002 | WO2002020490A3 Process to produce halo-4-phenoxyquinolines |
| 06/13/2002 | WO2001083438A3 New gamma selective retinoids |
| 06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
| 06/13/2002 | DE10060145C1 Chinolin-Derivate, ihre Verwendung und diese enthaltende pharmazeutische Zusammensetzung Quinoline derivatives, their use and pharmaceutical composition containing them |
| 06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1212301A1 Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 06/12/2002 | EP0775146B1 Novel process for the preparation of diisopinocampheylchloroborane |
| 06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
| 06/12/2002 | EP0460062B1 Huperzine a analogs |
| 06/12/2002 | CN1353692A Betz 2-adrenoceptor agonists |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/11/2002 | US6403607 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403585 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 06/06/2002 | WO2002044166A1 Substituted quinolines as antitumor agents |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044133A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
| 06/06/2002 | WO2002043667A2 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 06/06/2002 | WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 06/06/2002 | WO2002014294A3 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 06/06/2002 | WO2001085692A3 An improved process for the preparation of quinolone derivatives |
| 06/06/2002 | US20020068827 Quinoline-4-carboxamide derivatives, their preparation and their use as neurokinin 3 ( NK-3 ) - and neurokinin 2 ( NK-3 ) receptor antagonists |
| 06/06/2002 | US20020068751 Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists |
| 06/06/2002 | US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases |
| 06/06/2002 | US20020068734 Nitrogen-containing heterocyclic compounds |
| 06/06/2002 | CA2430061A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors |
| 06/06/2002 | CA2427255A1 Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 06/05/2002 | EP1211257A2 Metal coordination compound, luminescence device and display apparatus |
| 06/05/2002 | EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists |
| 06/05/2002 | EP1003719B1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives |
| 06/05/2002 | EP0937054B1 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 06/05/2002 | CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 06/05/2002 | CN1352635A Quinoline derivatives as inhibitors of MEK enzymes |
| 06/05/2002 | CN1352631A Aromatic amides |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | US6399774 Compounds having activity as inhibitors of cytochrome P450RAI |
| 06/04/2002 | US6399223 Compound for use in organic EL device and organic EL device |
| 06/04/2002 | CA2067929C Piperazine derivatives |
| 06/04/2002 | CA2020667C 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same |
| 05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2002022599A3 Chemokine receptor binding heterocyclic compounds |
| 05/30/2002 | WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 05/30/2002 | WO2002014275A3 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
| 05/30/2002 | WO2001064646A3 Hydrazones and analogs as cholesterol lowering agents |
| 05/30/2002 | WO2001021160B1 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| 05/30/2002 | US20020065299 Administering for therapy of mitochondria medited disease |
| 05/30/2002 | US20020065298 Mitochondria protecting agents for treating mitochondria associated diseases |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
| 05/30/2002 | US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP0678021B1 Methods for the improvement of cognition with partial agonists of the glycine nmda receptor complex |
| 05/29/2002 | CN1351601A Heterocyclic compounds binding chemotactic factor receptor |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/28/2002 | US6395751 Synergistic mixture; anticholesterol agents |
| 05/28/2002 | US6395750 Drugs for the treatment of malignant tumors |
| 05/28/2002 | US6395749 Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
| 05/28/2002 | US6395724 Multibinding inhibitors of cyclooxygenase-2 |
| 05/23/2002 | WO2002040474A2 Heterocyclylalkyl piperidine derivatives and their use as antimicrobial agents |
| 05/23/2002 | WO2002040154A1 Catalysts comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalysts |
| 05/23/2002 | WO2001081340A3 Heterocycles that are inhibitors of impdh enzyme |
| 05/23/2002 | US20020062024 Hetero-tetrahydroquinolines |
| 05/23/2002 | US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/23/2002 | US20020061908 S-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methy l-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid arginine salt microbiocides |
| 05/23/2002 | US20020061895 6-fluoro-1,4-dihydro-7-[4-(2-hydroxyiminoethyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid derivatives, their preparation and pharmaceutical compositions |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | US20020061886 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | CA2429311A1 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing the same |
| 05/22/2002 | EP1207152A2 Pesticides |
| 05/22/2002 | EP1206505A1 Electron-driven chirality switches |
| 05/22/2002 | EP0923510B1 Method for nitration of aromatic compounds |
| 05/22/2002 | EP0747341B1 Process for producing optically active mevalonolactone compounds |
| 05/22/2002 | EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 05/22/2002 | CN1350524A Quinoline derivatives as inhibitors of MEK enzymes |
| 05/22/2002 | CN1350522A New process |
| 05/22/2002 | CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 05/22/2002 | CN1349989A 4-hydroxyl-piperidine derivative |
| 05/21/2002 | US6392048 Process for preparing carbocyclic or heterocyclic nitriles by vapor phase ammoxidation |
| 05/21/2002 | US6392046 Aids therapy |
| 05/21/2002 | US6391878 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 05/21/2002 | US6391877 Eating disorders; sexual disorders; antidepressants; antiepileptic agents |
| 05/21/2002 | US6391064 Composition for hair dyeing comprising condensates of quinoline-5, 8-diones or of quinoxaline-5,8-diones and substituted pyrroles, anilines or indoles |
| 05/16/2002 | WO2002038548A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 05/16/2002 | WO2002038547A1 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2002026697A3 Aromatic derivatives with hiv integrase inhibitory properties |
| 05/16/2002 | WO2002020488A3 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 05/16/2002 | US20020056827 Piezoelectric element and process for production thereof |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |